724 related articles for article (PubMed ID: 12546613)
1. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.
Giannini E; Risso D; Botta F; Chiarbonello B; Fasoli A; Malfatti F; Romagnoli P; Testa E; Ceppa P; Testa R
Arch Intern Med; 2003 Jan; 163(2):218-24. PubMed ID: 12546613
[TBL] [Abstract][Full Text] [Related]
2. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
Park GJ; Lin BP; Ngu MC; Jones DB; Katelaris PH
J Gastroenterol Hepatol; 2000 Apr; 15(4):386-90. PubMed ID: 10824882
[TBL] [Abstract][Full Text] [Related]
3. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
4. Progressive liver functional impairment is associated with an increase in AST/ALT ratio.
Giannini E; Botta F; Fasoli A; Ceppa P; Risso D; Lantieri PB; Celle G; Testa R
Dig Dis Sci; 1999 Jun; 44(6):1249-53. PubMed ID: 10389705
[TBL] [Abstract][Full Text] [Related]
5. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
Sheth SG; Flamm SL; Gordon FD; Chopra S
Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
[TBL] [Abstract][Full Text] [Related]
6. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
[TBL] [Abstract][Full Text] [Related]
7. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.
Reedy DW; Loo AT; Levine RA
Dig Dis Sci; 1998 Sep; 43(9):2156-9. PubMed ID: 9753286
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
[TBL] [Abstract][Full Text] [Related]
9. A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice.
Giannini EG; Zaman A; Ceppa P; Mastracci L; Risso D; Testa R
J Clin Gastroenterol; 2006 Jul; 40(6):521-7. PubMed ID: 16825935
[TBL] [Abstract][Full Text] [Related]
10. AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.
Guéchot J; Boisson RC; Zarski JP; Sturm N; Calès P; Lasnier E;
Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):467-72. PubMed ID: 23932706
[TBL] [Abstract][Full Text] [Related]
11. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
12. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
Nyblom H; Björnsson E; Simrén M; Aldenborg F; Almer S; Olsson R
Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
[TBL] [Abstract][Full Text] [Related]
13. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
[TBL] [Abstract][Full Text] [Related]
14. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
Imperiale TF; Said AT; Cummings OW; Born LJ
Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
[TBL] [Abstract][Full Text] [Related]
15. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression.
Zechini B; Pasquazzi C; Aceti A
Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):891-6. PubMed ID: 15316414
[TBL] [Abstract][Full Text] [Related]
16. Serum aminotransferase levels and platelet count as predictive factor of fibrosis and cirrhosis in patients with chronic hepatitis C infection.
Khokhar N
J Pak Med Assoc; 2003 Mar; 53(3):101-4. PubMed ID: 12779023
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
18. Alanine aminotransferase/aspartate aminotransferase ratio reversal and prolonged prothrombin time: a specific indicator of hepatic cirrhosis.
Siddiqi AI; Siddiqeh M; Mehmood A; Siddiqui AM
J Ayub Med Coll Abbottabad; 2007; 19(3):22-4. PubMed ID: 18444585
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.
Forns X; Ampurdanès S; Sanchez-Tapias JM; Guilera M; Sans M; Sánchez-Fueyo A; Quintó L; Joya P; Bruguera M; Rodés J
J Hepatol; 2001 Aug; 35(2):265-71. PubMed ID: 11580150
[TBL] [Abstract][Full Text] [Related]
20. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.
Williams AL; Hoofnagle JH
Gastroenterology; 1988 Sep; 95(3):734-9. PubMed ID: 3135226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
